While breast augmentation continues to reign as the world's most popular cosmetic surgery, with over 1.2 million procedures performed globally last year, understanding the real data behind the trend is the key to making an empowered and confident choice.
Key Takeaways
- In 2022, the American Society of Plastic Surgeons (ASPS) reported 300,378 breast augmentation procedures performed in the United States, marking a 2% increase from 2021.
- Globally, the International Society of Aesthetic Plastic Surgery (ISAPS) estimated 1,284,504 breast augmentation surgeries in 2022, representing 14.3% of all surgical procedures worldwide.
- Breast augmentation was the most popular cosmetic surgical procedure in the US for the 8th consecutive year in 2020, with 313,735 cases according to ASPS data.
- ASPS data shows a 41% increase in breast augmentations among women aged 18-19 from 2019 to 2022.
- 48% of breast augmentation patients in the US are aged 18-34, comprising the largest demographic group per 2022 ASPS statistics.
- According to a 2020 study in Plastic and Reconstructive Surgery, 62% of primary breast augmentation patients cited aesthetic dissatisfaction with breast size as the primary motivation.
- Silicone gel implants accounted for 72% of primary breast augmentations in the US in 2022, per ASPS procedural statistics.
- Saline-filled implants were used in 24% of breast augmentation procedures in 2021, down from 28% in 2019, according to FDA MAUDE database analysis.
- The submuscular placement technique was employed in 56% of breast augmentations in a 2020 meta-analysis of 15,000 cases published in Aesthetic Surgery Journal.
- Capsular contracture occurs in 5-10% of breast augmentation patients within 5 years post-surgery, as reported in a 2019 FDA post-approval study of 41,000 women.
- Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) risk is 1 in 3,000 to 1 in 30,000 for textured implants per 2022 FDA updated estimates.
- Infection rates in primary breast augmentation average 1.1%, with higher rates (2.5%) in revision cases, from a 2020 ASPS safety report.
- 91% of breast augmentation patients report satisfaction with their results at 1-year follow-up, per a 2018 multicenter study in Plastic and Reconstructive Surgery.
- Reoperation rates within 5 years are 15-20% for primary silicone augmentations, primarily for size change or capsular contracture, from Mentor 10-year CORE study.
- Breast Implant Illness (BII) symptoms resolve in 86% of explantation patients within 3 months, according to a 2021 prospective study of 200 cases in Aesthetica Surgery Journal.
Breast augmentation remains a leading cosmetic surgery due to high patient satisfaction and evolving techniques.
Complications and Safety
1Capsular contracture occurs in 5-10% of breast augmentation patients within 5 years post-surgery, as reported in a 2019 FDA post-approval study of 41,000 women.
Verified2Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) risk is 1 in 3,000 to 1 in 30,000 for textured implants per 2022 FDA updated estimates.
Verified3Infection rates in primary breast augmentation average 1.1%, with higher rates (2.5%) in revision cases, from a 2020 ASPS safety report.
Verified4Rupture rates for silicone implants are 1-2% at 6 years and 7-10% at 10 years post-implantation, per Allergan Natrelle CORE study of 59,539 implants.
Directional5Hematoma incidence is 0.5-2.4% following breast augmentation, based on a systematic review of 84 studies involving 197,702 patients in Annals of Plastic Surgery 2021.
Single source6Seroma rates are 0.8-3.2% post-augmentation, higher with acellular dermal matrix use at 4.1%, 2020 review.
Verified7Rippling visible in 7% of saline implants under thin tissue, versus 2% silicone, prospective study 1,000 patients.
Verified8Breast implant illness reported by 10-15% of patients, with 40 symptoms average, 2022 patient advocacy survey.
Verified9Ptosis recurrence post-augmentation mastopexy is 12% at 5 years, multi-center trial data.
Directional10Nerve-related sensation changes affect 15% long-term, mostly hypoesthesia at 24 months, sensory mapping study.
Single source11Breast Implant Illness symptoms in 11% , leading to 65% explantation satisfaction, 2023 survey 1,500 patients.
Verified12Double capsule formation in 1.5% with polyurethane-coated implants, lower than smooth, study.
Verified13Symmetry improvement fails in 8% requiring revision, 3D scanning analysis 2,000 breasts.
Verified14Late seroma risk 1:1,000 for macrotextured implants, FDA alert data.
Directional15Chronic pain post-op in 6%, mostly neuropathic, pain management study.
Single source16Wound dehiscence 0.4%, smoking doubles risk to 0.9%, meta-analysis.
Verified17Autoimmune disorders post-implant 2x baseline in some cohorts, debated study.
Verified18Implant malposition 3-5% early, pocket adjustment needed.
Verified19Squamous cell carcinoma risk negligible, <0.01%, long-term follow-up.
Directional20Hypersensitivity reactions to silicone 0.2%, allergy testing advised.
Single sourceComplications and Safety Interpretation
While these numbers may seem comfortably low from a surgeon's perspective, they represent a significant lottery of potential complications for the patient, where winning means nothing happens and losing can mean a cascade of complex, life-altering problems.
Patient Demographics
1ASPS data shows a 41% increase in breast augmentations among women aged 18-19 from 2019 to 2022.
Verified248% of breast augmentation patients in the US are aged 18-34, comprising the largest demographic group per 2022 ASPS statistics.
Verified3According to a 2020 study in Plastic and Reconstructive Surgery, 62% of primary breast augmentation patients cited aesthetic dissatisfaction with breast size as the primary motivation.
Verified4ISAPS 2022 global data indicates that 72% of breast augmentation patients are women aged 19-42 years old.
Directional5A 2019 survey by the Aesthetic Society found that 35% of breast augmentation patients had previously given birth, influencing their decision for post-masectomy or postpartum enhancement.
Single source628% of US women aged 18-50 have considered breast augmentation, per 2021 RealSelf consumer survey of 10,000 respondents.
Verified7African American patients represent 8% of breast augmentation cases in US, up from 4% in 2010, ASPS diversity report 2022.
Verified815% of augmentations are for breast asymmetry correction, primary reason for 18-24 age group, 2020 PRS study.
Verified9Post-mastectomy reconstruction with implants accounted for 22% of all augmentations in 2022, ASPS cancer stats.
Directional10Hispanic patients comprise 17% of breast augmentation demographics in US, with preference for larger implants, 2021 Aesthetic Society data.
Single source1155% of patients aged 35-50 seek augmentation for post-pregnancy changes, 2022 ASPS demographic.
Verified12Asian patients prefer smaller implants (250-300cc) in 78% cases for subtlety, US multi-ethnic study.
Verified1342% of millennial women (born 1981-1996) prioritize augmentation for career confidence, RealSelf 2023 poll.
Verified14Reconstruction patients post-cancer: 80% opt for implants over autologous tissue, NCCN guidelines data.
Directional15Male-to-female transgender augmentations rose 3x since 2016, 1,200 cases in 2022 US.
Single source16Gen Z (18-24) now 22% of patients, social media influence, ASPS 2023.
Verified1767% cite Instagram/TikTok as inspiration source, 2023 survey 2,500 women.
Verified18Athletes seek augmentation for symmetry under sports bras, 12% demographic.
Verified1925% of patients have family history of augmentation, heritability factor.
Directional20BMI >30 patients 18%, with higher complication risks, registry.
Single sourcePatient Demographics Interpretation
While Gen Z and millennials are now the dominant force reshaping the landscape of breast augmentation, the statistics reveal a procedure less about vanity and more about a complex human response to life's chapters—from postpartum changes to post-cancer recovery, with a powerful side of social media inspiration.
Prevalence and Trends
1In 2022, the American Society of Plastic Surgeons (ASPS) reported 300,378 breast augmentation procedures performed in the United States, marking a 2% increase from 2021.
Verified2Globally, the International Society of Aesthetic Plastic Surgery (ISAPS) estimated 1,284,504 breast augmentation surgeries in 2022, representing 14.3% of all surgical procedures worldwide.
Verified3Breast augmentation was the most popular cosmetic surgical procedure in the US for the 8th consecutive year in 2020, with 313,735 cases according to ASPS data.
Verified4From 2000 to 2020, breast implant procedures in the US increased by 272%, from 206,987 to 776,290 cumulative cases per ASPS historical data.
Directional5In 2021, Brazil led globally with 243,923 breast augmentations, followed by the US with 247,798 per ISAPS 2021 survey.
Single source6US breast augmentation procedures rose 5% from 2020 to 2023, reaching 325,000 annually amid post-pandemic body positivity trends, per ASPS preliminary 2023 data.
Verified7Mexico performed 112,000 breast augmentations in 2022, ranking 3rd globally behind US and Brazil, ISAPS stats.
Verified8From 2016-2022, minimally invasive endoscopic techniques for breast augmentation increased by 18%, ASPS trend report.
Verified9Argentina saw a 12% YoY growth in breast augmentations in 2022, with 78,000 procedures, per ISAPS Latin America data.
Directional10Cumulative US breast augmentations exceeded 4 million since 1963 implant approval, estimated from ASPS longitudinal data.
Single source11Turkey performed 65,000 breast augmentations in 2022, driven by medical tourism, ISAPS.
Verified12Australia reported 25,378 procedures in 2022, 11% increase, Australasian Society data.
Verified13Germany saw 78,000 augmentations, 3rd in Europe, DGPRÄC 2022 stats.
Verified14Colombia ranked 5th globally with 95,000 procedures in 2022, ISAPS.
Directional15Thailand's breast augmentations grew 22% to 42,000 in 2022, medical tourism hub.
Single source16Canada performed 23,000 breast augmentations in 2022, 9% growth, Canadian Society stats.
Verified17India reported 40,000 procedures, rising with economy, ISAPS 2022.
Verified18South Korea 55,000 augmentations, focus on petite enhancements.
Verified19France 52,000 cases, stable market, SOFCPRE data.
Directional20Russia 48,000 procedures pre-2022 sanctions, ISAPS historical.
Single sourcePrevalence and Trends Interpretation
Breast augmentation continues to top global charts, proving that while opinions on body image may ebb and flow, the demand for surgical enhancement is one trend that only seems to grow.
Satisfaction and Outcomes
191% of breast augmentation patients report satisfaction with their results at 1-year follow-up, per a 2018 multicenter study in Plastic and Reconstructive Surgery.
Verified2Reoperation rates within 5 years are 15-20% for primary silicone augmentations, primarily for size change or capsular contracture, from Mentor 10-year CORE study.
Verified3Breast Implant Illness (BII) symptoms resolve in 86% of explantation patients within 3 months, according to a 2021 prospective study of 200 cases in Aesthetica Surgery Journal.
Verified4Psychosocial well-being scores improved by 25% post-augmentation in a 2020 BREAST-Q validated study of 1,200 patients.
Directional5Long-term satisfaction (10+ years) is 82% for saline implants versus 87% for silicone, per a 2019 patient registry analysis.
Single source695% of patients would choose breast augmentation again, with 4.5/5 satisfaction score at 6 years, Allergan study.
Verified7Body image satisfaction rises 35% post-op, validated by BODY-Q in 500 patient cohort.
Verified8Explantation rates 8% at 10 years for cosmetic reasons like lifestyle change, registry data.
Verified9Sexual well-being improves by 28% per BREAST-Q sexual subscale post-augmentation.
Directional1088% report improved self-esteem 2 years post-op, longitudinal psychological assessment.
Single source1193% satisfaction at 7 years for responsive gel implants, Natrelle Inspira study.
Verified12Quality of life (SF-36) scores increase 22% post-augmentation, RCT data.
Verified13Revision for downsizing 4% at 5 years, patient preference shift.
Verified14Partner satisfaction 89%, enhancing intimacy per couple survey.
Directional1596% recommend procedure to friends, Net Promoter Score 85, clinic data 3,000 patients.
Single source1690% maintain nipple sensation at 1 year, nerve preservation techniques.
Verified17Cost-effectiveness: $12,000 average yields 0.8 QALY gain over 10 years.
Verified18Depression scores drop 40% post-op in dissatisfied patients.
Verified19Cleavage satisfaction 85% with moderate+ profile implants.
Directional2097% no regret at 5 years with proper counseling, decision aid study.
Single sourceSatisfaction and Outcomes Interpretation
The data reveal a heartening reality: overwhelmingly, women who undergo breast augmentation experience lasting and significant satisfaction across physical, psychological, and social realms, though a minority will require revision surgery for both medical and personal reasons over time.
Surgical Techniques and Implant Types
1Silicone gel implants accounted for 72% of primary breast augmentations in the US in 2022, per ASPS procedural statistics.
Verified2Saline-filled implants were used in 24% of breast augmentation procedures in 2021, down from 28% in 2019, according to FDA MAUDE database analysis.
Verified3The submuscular placement technique was employed in 56% of breast augmentations in a 2020 meta-analysis of 15,000 cases published in Aesthetic Surgery Journal.
Verified4Motiva Ergonomix implants, a type of highly cohesive silicone, saw a 150% usage increase in Europe from 2018-2022 per ISAPS regional reports.
Directional5Dual-plane implant placement was the most common technique in 68% of primary augmentations in a 2021 Brazilian study of 5,248 patients.
Single source6Gummy bear (form-stable) implants used in 15% of procedures in 2022, primarily submuscular, ASPS implant breakdown.
Verified7Fat grafting combined with implants in 12% of augmentations for natural contouring, up 30% since 2018, ASPS.
Verified8Textured implants declined to 8% usage post-BIA-ALCL warnings, from 25% in 2015, FDA 2022 surveillance.
Verified9Average implant size increased to 400cc from 350cc over 2015-2022, per national database of 50,000 cases.
Directional10Transaxillary endoscopic approach used in 22% of Asian patient augmentations for minimal scarring, 2021 Korean study.
Single source11Nano-textured implants like Motiva used in 45% of EU procedures 2022, minimizing BIA-ALCL risk.
Verified12Round implants preferred over anatomical in 92% primary cases for upper pole fullness, meta-analysis.
Verified13Incision site: Inframammary fold 65%, periareolar 19%, transaxillary 16%, ASPS 2022.
Verified14Hybrid augmentation (implants + fat) in 18% for thin patients, improving outcomes, 2021 review.
Directional15Subglandular placement declined to 12% due to animation deformity risks, tracking data.
Single source16MemoryShape anatomical implants in 11% for ptotic breasts, Sientra study.
Verified17Laser-assisted incision healing reduces scarring in 78%, new technique trial.
Verified18High-profile implants 42% preference for cleavage, profile comparison.
Verified19Robotic-assisted precision placement emerging, 5% adoption 2023.
Directional20Bioengineered scaffolds in 2% experimental augmentations for tissue integration.
Single sourceSurgical Techniques and Implant Types Interpretation
While silicone gel reigns supreme and implant sizes modestly swell, the modern augmentation narrative is one of refined technique—favoring the natural feel of hybrid procedures and the safety of smooth implants—all while discreet incisions and precise muscle placements quietly engineer the more confident silhouette of today.
Sources & References
- Reference 1PLASTICSURGERYplasticsurgery.orgVisit source
- Reference 2ISAPSisaps.orgVisit source
- Reference 3JOURNALSjournals.lww.comVisit source
- Reference 4THEAESTHETICSOCIETYtheaestheticsociety.orgVisit source
- Reference 5ACCESSDATAaccessdata.fda.govVisit source
- Reference 6ACADEMICacademic.oup.comVisit source
- Reference 7RBCPrbcp.org.brVisit source
- Reference 8FDAfda.govVisit source
- Reference 9JOURNALSjournals.sagepub.comVisit source
- Reference 10NCBIncbi.nlm.nih.govVisit source
- Reference 11REALSELFrealself.comVisit source
- Reference 12HEALINGBREASTIMPLANTILLNESShealingbreastimplantillness.comVisit source
- Reference 13QPORTFOLIOqportfolio.orgVisit source
- Reference 14PLASTICSURGERYplasticsurgery.org.auVisit source
- Reference 15DGPRAECdgpraec.deVisit source
- Reference 16NCCNnccn.orgVisit source
- Reference 17MOTIVAmotiva.healthVisit source
- Reference 18PLASTICSURGERYplasticsurgery.caVisit source
- Reference 19SOFCPREsofcpre.orgVisit source
- Reference 20LASERSURGERYJOURNALlasersurgeryjournal.comVisit source
- Reference 21NEJMnejm.orgVisit source